CytoGenix, Inc. (CYGX)
Interview with: Dr. Malcolm Skolnick, Chairman and CEO
Business News, Financial News, Stocks, Money & Investment Ideas, CEO Interview
and Information on their products and services based on
proprietary DNA expression technology, in pre-clinical development including, anti-herpes,
anti-psoriasis and anti-inflammatory topical creams. |
Cover Story
CEOCFO
Interview Index
CEOCFO Current
Issue
Future Features
Analyst Interviews
Corporate
Financials
Archived Interviews
About CEOCFOinterviews.com
Contact
& Ordering |
CytoGenix
- going after diseases that they can approach with a topical delivery such as herpes and
the human papaloma virus that causes cervical cancer
Healthcare
Biotechnology
(CYGX-OTC)
CytoGenix, Inc.
Dr. Malcolm Skolnick
Chairman and
Chief Executive Officer
Interview conducted by:
Lynn Fosse
Senior Editor
CEOCFOinterviews.com
October 2003
Left click below to view
this Newsletter story and:
Request
an Investor Kit
Instant Access:
To find out more about:
CytoGenix,
Inc. (CYGX)
you may order the complete text of our
interview. To view a copy of this highly informative interview, left click here: ViewCYGX
disclaimer
|
